MODULATION OF THE CYTOTOXIC RESPONSE AGAINST ALLOGENEIC TUMOR CELLS IN CULTURE BY ADRIAMYCINTOMAZIC V; EHRKE MJ; MIHICH E et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 8; PP. 2748-2755; BIBL. 27 REF.Article

AUGMENTATION OF THE DEVELOPMENT OF IMMUNE RESPONSES OF MICE AGAINST ALLOGENEIC TUMOR CELLS AFTER ADRIAMYCIN TREATMENTTOMAZIC V; EHRKE MJ; MIHICH E et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 9; PART. 1; PP. 3370-3376; BIBL. 36 REF.Article

SELECTIVITY OF INHIBITION BY ANTICANCER AGENTS OF MOUSE SPLEEN IMMUNE EFFECTOR FUNCTIONS INVOLVED IN RESPONSES TO SHEEP ERYTHROCYTES.EHRKE MJ; COHEN SA; MIHICH E et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 3; PP. 521-530; BIBL. 43 REF.Article

MOUSE EFFECTOR FUNCTIONS INVOLVED IN THE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO XENOGENEIC ERYTHROCYTESCOHEN SA; EHRKE MJ; MIHICH E et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 4; PP. 1007-1012; BIBL. 21 REF.Article

ADRIAMYCIN INDUCED IMMUNOMODULATION: DEPENDENCE UPON TIME OF ADMINISTRATIONEHRKE MJ; TOMAZIC V; RYOYAMA K et al.1983; INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY; ISSN 0192-0561; USA; DA. 1983; VOL. 5; NO 1; PP. 43-48; BIBL. 23 REF.Article

INHIBITION BY SELECTED ANTICANCER AGENTS OF THE DEVELOPMENT OF PRIMARY CELL-MEDIATED IMMUNITY AGAINST ALLOGENEIC TUMOR CELLS IN CULTUREORSINI F; EPPOLITO C; EHRKE MJ et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 211-218; BIBL. 19 REF.Article